Contravisory Investment Management’s LeMaitre Vascular LMAT Stock Holding History

Contravisory Investment Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$233K	Buy	+2,430	New	+$249K	0.04%	206

Other funds holding LMAT

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return

Chatham Capital Group Savannah, Georgia $783M AUM 31.99% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Contravisory Investment Management's LMAT Position: Q2 2026 in Review

Contravisory Investment Management opened a new position in LeMaitre Vascular (LMAT) in Q2 2026: 2,430 shares worth $233K. The stake represents 0.04% of the portfolio and ranks #206 among its holdings.

41 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Contravisory Investment Management held 2,430 shares of LeMaitre Vascular worth $233K as of Q2 2026.
LeMaitre Vascular was a new Contravisory Investment Management position in Q2 2026.
LeMaitre Vascular made up 0.04% of Contravisory Investment Management's portfolio in Q2 2026, its #206 holding.
41 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Contravisory Investment Management's 13F filing for Q2 2026, filed 9 Jul 2026.